<DOC>
	<DOCNO>NCT01296698</DOCNO>
	<brief_summary>This study see new nicotine replacement therapy safely help people quit smoke use way would sell pharmacy use home . Approximately 1500 subject enrol study . The study require participant use treatment 12 week 14-week follow-up period . The study conduct approximately 20 pharmacy across United States . At first visit pharmacy , participant ask question see eligible participate . Participants ask sign consent form agree participate . Participants answer question , blow machine measure carbon monoxide ( CO ) level make sure qualify trial . Participants ask go nearby dentist look mouth . Participants go back pharmacy qualify , give supply assign treatment . They equal chance receive treatment drug one drug . They give diary keep track much treatment use . Subjects go pharmacy four time hand diary blow machine measure CO level . At last visit , subject mouth examine dentist mouth check . Subjects receive four telephone call study ask question . After 12 week treatment period , subject receive two three telephone call , ask answer question . Participants may ask come back pharmacy two time blow carbon monoxide machine .</brief_summary>
	<brief_title>Study Determine New Nicotine Replacement Therapy Can Safely Help Smokers Quit Smoking</brief_title>
	<detailed_description>This trial multi-center , randomize , double blind , placebo-controlled parallel group study measure efficacy safety new nicotine replacement therapy smoke cessation naturalistic environment . Subjects randomize 2:1 ratio ( active placebo ) . It anticipate data 450 active treatment group Week 12 require safety analysis . In order obtain number subject , approximately 1500 subject need enrol Use phase study , 1000 active arm 500 placebo arm . Based direction use Drug Facts label , study include six week full study drug treatment six week progressive taper drug treatment ( Weeks 1-12 ) . There 14-week post-use follow period . This trial conduct three sequential phase : Enrollment ( baseline ) , Use Post-use Follow-up . The Enrollment Phase conduct approximately 20 pharmacy nine diverse geographical area continental United States . Subjects qualify participate study give three unit investigational product , subject diary track investigational product use medical problem worksheet assist collection AE information . Subjects also give small hand counter encourage use help keep track number dos use day . Subjects also give card contact information pharmacy study nurse . Where need , subject also speak study physician . During Use Phase , collection data relate efficacy accomplish four return visit pharmacy ( week 2 , 4 , 6 12 ) . Self-reported abstinence verify carbon monoxide ( CO ) measurement obtain pharmacy visit . Subjects give subject use diary follow-up re-supply visit complete diary collect time subject return pharmacy . Subjects return pharmacy additional supply time participation . Empty unit return visit . Safety data collect four telephone interview , conduct trained nurse interviewer , week 2 , 4 , 6 12 . If subject report adverse event visit ( return visit resupply visit ) , information immediately forward nurse interviewer follow-up . Subjects may also initiate call study nurse discuss health problem . All AE information collect reviewed physician adverse event collect . A standardized visual mouth examination conduct trained dentist enrollment visit Week 12 return visit . During Post-use Follow-up period , self-reported efficacy safety data collect two telephone interview initiate trained nurse interviewer ( week 16 26 ) . Subjects report abstinence since last visit abstinence prior seven day two interview ask return pharmacy verify abstinence exhale CO measurement . An additional telephone interview conduct Week-12 Week-16 , train nurse interviewer , administer End Treatment question subject report follow product use behavior inconsistent direction Drug Facts label : Use 64 dos 24-hour period least one time use 4 dos per hour least one time base diary self report .</detailed_description>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Nicotine</mesh_term>
	<criteria>Subjects must males female 18 year age old currently smoke cigarette willing stop smoking Subjects must recent history unstable angina , myocardial infarction stroke They must suspect malignant and/or erosive oral lesion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Smoking Cessation</keyword>
	<keyword>Tobacco Use Disorder</keyword>
</DOC>